The international consultancy and construction company Mace has been appointed as principal contractor by London-based developer Precis Group to deliver MSD’s UK headquarters and discovery centre within Belgrove House on Euston Road. Once complete, it will be used for breakthrough research focusing on diseases of ageing and human biology to discover new life-saving medicines.Belgrove House is located directly opposite King’s Cross Square and St Pancras International and King’s Cross station with connectivity to the UK and into Europe. The site is located within the capital’s ‘Knowledge Quarter’, the development will become home for approximately 850 clinical researchers and office staff.Alongside the specialised life science space, it will also deliver meaningful benefits for the local community including an education and outreach centre, publicly accessible auditorium and a new step-free entrance for King’s Cross station. The global healthcare giant will also be delivering an educational outreach programme in collaboration with Camden STEAM.Designed by architects Allford Hall Monaghan Morris, the ten-storey development will deliver circa 180,000 sq.ft of net lettable space for MSD.It has been designed using sustainable materials and includes an innovative double-skin façade to reduce solar gain. Carbon emissions generated through construction, operation and future fit-out will be reduced.Construction will begin in April 2023, with completion expected at the end of 2025.
The international consultancy and construction company Mace has been appointed as principal contractor by London-based developer Precis Group to deliver MSD’s UK headquarters and discovery centre within Belgrove House on Euston Road. Once complete, it will be used for breakthrough research focusing on diseases of ageing and human biology to discover new life-saving medicines.Belgrove House is located directly opposite King’s Cross Square and St Pancras International and King’s Cross station with connectivity to the UK and into Europe. The site is located within the capital’s ‘Knowledge Quarter’, the development will become home for approximately 850 clinical researchers and office staff.Alongside the specialised life science space, it will also deliver meaningful benefits for the local community including an education and outreach centre, publicly accessible auditorium and a new step-free entrance for King’s Cross station. The global healthcare giant will also be delivering an educational outreach programme in collaboration with Camden STEAM.Designed by architects Allford Hall Monaghan Morris, the ten-storey development will deliver circa 180,000 sq.ft of net lettable space for MSD.It has been designed using sustainable materials and includes an innovative double-skin façade to reduce solar gain. Carbon emissions generated through construction, operation and future fit-out will be reduced.Construction will begin in April 2023, with completion expected at the end of 2025.
